$Tiger Brokers(TIGR)$

$GeoVax Labs Inc(GOVX)$

Next on our list of monkeypox stocks is GeoVax Labs (NASDAQ:GOVX). GeoVax is a clinical-stage, pre-revenue pharma company with a focus on vaccines and immunotherapies. Its current research programs center around Covid-19, various hemorrhagic fever viruses, Zika virus, malaria, and various forms of cancer. The company utilizes recombinant-DNA-based genetic engineering to develop its drugs.

In early August, GeoVax provided Q2 earnings. Loss per share was 18 cents, compared to a loss per share of 21 cents the prior year. Cash and equivalents totaled $30.9 million.

Recently, the company announced that its GEO-CM04S1 vaccine was being evaluated for effectiveness against monkeypox. GeoVax also revealed that its hemorrhagic fever virus vaccine will also be assessed as a possible candidate for monkeypox. GeoVax anticipates both vaccines will show effectiveness against the virus.

Yet, despite the potential, GOVX stock has lost close to a third of its value since January. Shares are trading at 80.4 times sales.

# Tiger Think Tank - Week 1

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment15

  • Top
  • Latest
  • jasmine_tan
    ·2022-09-11
    thanks for sharing
    Reply
    Report
  • Newcomer007
    ·2022-09-11
    like
    Reply
    Report
  • fcbergkamp
    ·2022-09-11
    Ok
    Reply
    Report
  • ICEsh00ter
    ·2022-09-11
    🐯
    Reply
    Report
  • soosoo
    ·2022-09-11
    okay
    Reply
    Report
  • xSorrymaker
    ·2022-09-11
    1
    Reply
    Report
  • Lollollol
    ·2022-09-11
    K
    Reply
    Report
  • Big Little
    ·2022-09-11
    Ok
    Reply
    Report
  • Kundos
    ·2022-09-11
    ok
    Reply
    Report
    Fold Replies
  • cyberage79
    ·2022-09-11
    nice
    Reply
    Report
  • WayneLee
    ·2022-09-11
    Okay
    Reply
    Report
  • Berrylike
    ·2022-09-11
    👍
    Reply
    Report
  • ChongTingWei
    ·2022-09-11
    Noce
    Reply
    Report
  • Kiwo1511
    ·2022-09-11
    [smile]
    Reply
    Report